These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3307013)

  • 1. A tier system for developmental toxicity evaluations based on considerations of exposure and effect relationships.
    Johnson EM
    Teratology; 1987 Jun; 35(3):405-27. PubMed ID: 3307013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U.S. EPA's ToxRefDB.
    Knudsen TB; Martin MT; Kavlock RJ; Judson RS; Dix DJ; Singh AV
    Reprod Toxicol; 2009 Sep; 28(2):209-19. PubMed ID: 19446433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of chick embryo in screening for teratogenicity.
    Kotwani A
    Indian J Physiol Pharmacol; 1998 Apr; 42(2):189-204. PubMed ID: 10225046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro tests in screening teratogens: considerations to aid the validation process.
    Kimmel GL
    Prog Clin Biol Res; 1985; 163C():259-63. PubMed ID: 3991628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new frontier in understanding the mechanisms of developmental abnormalities.
    Kimmel CA; Generoso WM; Thomas RD; Bakshi KS
    Toxicol Appl Pharmacol; 1993 Apr; 119(2):159-65. PubMed ID: 7683149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the adult developmental relationship in prescreening for developmental hazards.
    Johnson EM; Christian MS; Dansky L; Gabel BE
    Teratog Carcinog Mutagen; 1987; 7(3):273-85. PubMed ID: 2888206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of alternative methods for developmental toxicity testing.
    Piersma AH
    Toxicol Lett; 2004 Apr; 149(1-3):147-53. PubMed ID: 15093260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
    Webster WS; Brown-Woodman PD; Ritchie HE
    Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strengths and limitations of using repeat-dose toxicity studies to predict effects on fertility.
    Dent MP
    Regul Toxicol Pharmacol; 2007 Aug; 48(3):241-58. PubMed ID: 17512650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for developmental toxicity testing of chemicals in Japan.
    Tanimura T
    Neurobehav Toxicol Teratol; 1985; 7(6):647-52. PubMed ID: 3835459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for the development of validated screening tests that measure developmental toxicity potential: view of one skeptic.
    Mirkes PE
    Teratology; 1996 Jun; 53(6):334-8. PubMed ID: 8910978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the embryotoxic potential of ten chemicals in the whole mouse embryo culture.
    Van Maele-Fabry G; Picard JJ
    Teratology; 1987 Aug; 36(1):95-106. PubMed ID: 3672382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP-CERHR expert panel report on the reproductive and developmental toxicity of methanol.
    Shelby M; Portier C; Goldman L; Moore J; Iannucci A; Jahnke G; Donkin S;
    Reprod Toxicol; 2004 May; 18(3):303-90. PubMed ID: 15082073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A subvertebrate system for rapid determination of potential teratogenic hazards.
    Johnson EM
    J Environ Pathol Toxicol; 1980 Nov; 4(5-6):153-6. PubMed ID: 7217843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of developmental toxicity of chemicals exposed occupationally using whole embryo culture.
    Zhao SF; Zhang XC; Zhang LF; Zhou SS; Zhang F; Wang QF; Wang YL; Bao YS
    Int J Dev Biol; 1997 Apr; 41(2):275-82. PubMed ID: 9184335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of in vivo assays for endocrine disruption.
    Clode SA
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):35-43. PubMed ID: 16522518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
    Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.